lymphoma daudi Search Results


daudi  (ATCC)
95
ATCC daudi
Daudi, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pmc00109906-90-15-16?v=ATCC
Average 95 stars, based on 1 article reviews
daudi - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier


90
BioResource International Inc lymphoblastoid cell lines
Sequenom MassARRAY methylation data of (A) normal, somatic tissues, and (B) <t>lymphoblastoid</t> cell lines (95% confidence intervals are shown). (C) TES expression levels by quantitative RT-PCR were calculated relative to B2M expression and normalised to relative expression levels in the normal peripheral blood leukocyte sample (PBL2) (error bars are standard deviations).
Lymphoblastoid Cell Lines, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pmc04795691-62-0-13?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
lymphoblastoid cell lines - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Beijing Xiehe Pharmaceutical Co Ltd hek293t cells
(A) Schematic diagram of m 6 A detection with DART-seq in cultured cells. The YTH protein domain binds to m 6 A. When bound to APOBEC1, the APOBEC1 protein converts C-to-U in the vicinity of m 6 A. This results in a C-to-T mutation in cDNA. C-to-T mutations detected by RNA sequencing are indicative of m 6 A RNA modifications. (B) Left: Immunofluorescence (IF) of <t>HEK293T</t> cells transfected with Apobec1-Yth-HA- Egfp ( Yth-HA-E ) or Egfp-Apobec1-Yth-HA (E-YTH-HA ). Scale bar, 20μm, representative images are shown. Right: Quantification of EGFP and HA overlap. PCC: Pearson’s Correlation Coefficient. (C) Number of C-to-T editing events identified in each bulk DART-seq HEK293T cell replicate for Yth-E and E-Yth plasmids. Editing events identified in at least 2 replicates were considered for downstream analyses. The data was obtained following Apobec1-Yth-Egfp or Egfp-Apobec1-Yth transfection and EGFP FACS sorting. n=3, Rep: separately cultured replicate. (D) Metagene analysis showing m 6 A site counts along transcripts for Yth-E and E-Yth DART-seq results. 9% of all m 6 A sites occur in the first 10% of the 3’ UTR following the TTS for YTH-E, and 11% for E-YTH, respectively. Shown percentage indicates number of m 6 A sites upstream, within and downstream of coding sequence (CDS). (E) Metagene analysis showing m 6 A density 500nt 5’ and 500nt 3’ from stop codon (0nt) for YTH-E and E-YTH.
Hek293t Cells, supplied by Beijing Xiehe Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/bio_rxiv__2023__12__06__570314-225-0-5?v=Beijing+Xiehe+Pharmaceutical+Co+Ltd
Average 90 stars, based on 1 article reviews
hek293t cells - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CEM Corporation burkitt lymphoma daudi
(A) Schematic diagram of m 6 A detection with DART-seq in cultured cells. The YTH protein domain binds to m 6 A. When bound to APOBEC1, the APOBEC1 protein converts C-to-U in the vicinity of m 6 A. This results in a C-to-T mutation in cDNA. C-to-T mutations detected by RNA sequencing are indicative of m 6 A RNA modifications. (B) Left: Immunofluorescence (IF) of <t>HEK293T</t> cells transfected with Apobec1-Yth-HA- Egfp ( Yth-HA-E ) or Egfp-Apobec1-Yth-HA (E-YTH-HA ). Scale bar, 20μm, representative images are shown. Right: Quantification of EGFP and HA overlap. PCC: Pearson’s Correlation Coefficient. (C) Number of C-to-T editing events identified in each bulk DART-seq HEK293T cell replicate for Yth-E and E-Yth plasmids. Editing events identified in at least 2 replicates were considered for downstream analyses. The data was obtained following Apobec1-Yth-Egfp or Egfp-Apobec1-Yth transfection and EGFP FACS sorting. n=3, Rep: separately cultured replicate. (D) Metagene analysis showing m 6 A site counts along transcripts for Yth-E and E-Yth DART-seq results. 9% of all m 6 A sites occur in the first 10% of the 3’ UTR following the TTS for YTH-E, and 11% for E-YTH, respectively. Shown percentage indicates number of m 6 A sites upstream, within and downstream of coding sequence (CDS). (E) Metagene analysis showing m 6 A density 500nt 5’ and 500nt 3’ from stop codon (0nt) for YTH-E and E-YTH.
Burkitt Lymphoma Daudi, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pmc01508076-113-47-56?v=CEM+Corporation
Average 90 stars, based on 1 article reviews
burkitt lymphoma daudi - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
European Collection of Authenticated Cell Cultures daudi b-cell lymphoma line
V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with <t>Daudi</t> <t>cells,</t> <t>Raji</t> cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.
Daudi B Cell Lymphoma Line, supplied by European Collection of Authenticated Cell Cultures, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pmc07576882-40-0-6?v=European+Collection+of+Authenticated+Cell+Cultures
Average 90 stars, based on 1 article reviews
daudi b-cell lymphoma line - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science ebv-positive burkitt’s lymphoma cell line raji
V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with <t>Daudi</t> <t>cells,</t> <t>Raji</t> cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.
Ebv Positive Burkitt’s Lymphoma Cell Line Raji, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pmc07472350-46-1-29?v=National+Centre+for+Cell+Science
Average 90 stars, based on 1 article reviews
ebv-positive burkitt’s lymphoma cell line raji - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BioResource International Inc daudi cells b lymphoblast cell line from a burkitt lymphoma patient
V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with <t>Daudi</t> <t>cells,</t> <t>Raji</t> cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.
Daudi Cells B Lymphoblast Cell Line From A Burkitt Lymphoma Patient, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pm37310262-80-0-15?v=BioResource+International+Inc
Average 90 stars, based on 1 article reviews
daudi cells b lymphoblast cell line from a burkitt lymphoma patient - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

86
Procell Inc lymphoma cell line daudi
V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with <t>Daudi</t> <t>cells,</t> <t>Raji</t> cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.
Lymphoma Cell Line Daudi, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pm40903191-58-27-34?v=Procell+Inc
Average 86 stars, based on 1 article reviews
lymphoma cell line daudi - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

90
JCRB Cell Bank burkitt’s lymphoma cells line daudi
V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with <t>Daudi</t> <t>cells,</t> <t>Raji</t> cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.
Burkitt’s Lymphoma Cells Line Daudi, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lymphoma+daudi/pm16151644-30-8-17?v=JCRB+Cell+Bank
Average 90 stars, based on 1 article reviews
burkitt’s lymphoma cells line daudi - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Sequenom MassARRAY methylation data of (A) normal, somatic tissues, and (B) lymphoblastoid cell lines (95% confidence intervals are shown). (C) TES expression levels by quantitative RT-PCR were calculated relative to B2M expression and normalised to relative expression levels in the normal peripheral blood leukocyte sample (PBL2) (error bars are standard deviations).

Journal: PLoS ONE

Article Title: TESTIN Induces Rapid Death and Suppresses Proliferation in Childhood B Acute Lymphoblastic Leukaemia Cells

doi: 10.1371/journal.pone.0151341

Figure Lengend Snippet: Sequenom MassARRAY methylation data of (A) normal, somatic tissues, and (B) lymphoblastoid cell lines (95% confidence intervals are shown). (C) TES expression levels by quantitative RT-PCR were calculated relative to B2M expression and normalised to relative expression levels in the normal peripheral blood leukocyte sample (PBL2) (error bars are standard deviations).

Article Snippet: Lymphoblastoid cell lines were cultured as recommended by the ATCC or the RIKEN BioResource Center.

Techniques: Methylation, Expressing, Quantitative RT-PCR

(A) Schematic diagram of m 6 A detection with DART-seq in cultured cells. The YTH protein domain binds to m 6 A. When bound to APOBEC1, the APOBEC1 protein converts C-to-U in the vicinity of m 6 A. This results in a C-to-T mutation in cDNA. C-to-T mutations detected by RNA sequencing are indicative of m 6 A RNA modifications. (B) Left: Immunofluorescence (IF) of HEK293T cells transfected with Apobec1-Yth-HA- Egfp ( Yth-HA-E ) or Egfp-Apobec1-Yth-HA (E-YTH-HA ). Scale bar, 20μm, representative images are shown. Right: Quantification of EGFP and HA overlap. PCC: Pearson’s Correlation Coefficient. (C) Number of C-to-T editing events identified in each bulk DART-seq HEK293T cell replicate for Yth-E and E-Yth plasmids. Editing events identified in at least 2 replicates were considered for downstream analyses. The data was obtained following Apobec1-Yth-Egfp or Egfp-Apobec1-Yth transfection and EGFP FACS sorting. n=3, Rep: separately cultured replicate. (D) Metagene analysis showing m 6 A site counts along transcripts for Yth-E and E-Yth DART-seq results. 9% of all m 6 A sites occur in the first 10% of the 3’ UTR following the TTS for YTH-E, and 11% for E-YTH, respectively. Shown percentage indicates number of m 6 A sites upstream, within and downstream of coding sequence (CDS). (E) Metagene analysis showing m 6 A density 500nt 5’ and 500nt 3’ from stop codon (0nt) for YTH-E and E-YTH.

Journal: bioRxiv

Article Title: Single cell discovery of m 6 A RNA modifications in the hippocampus

doi: 10.1101/2023.12.06.570314

Figure Lengend Snippet: (A) Schematic diagram of m 6 A detection with DART-seq in cultured cells. The YTH protein domain binds to m 6 A. When bound to APOBEC1, the APOBEC1 protein converts C-to-U in the vicinity of m 6 A. This results in a C-to-T mutation in cDNA. C-to-T mutations detected by RNA sequencing are indicative of m 6 A RNA modifications. (B) Left: Immunofluorescence (IF) of HEK293T cells transfected with Apobec1-Yth-HA- Egfp ( Yth-HA-E ) or Egfp-Apobec1-Yth-HA (E-YTH-HA ). Scale bar, 20μm, representative images are shown. Right: Quantification of EGFP and HA overlap. PCC: Pearson’s Correlation Coefficient. (C) Number of C-to-T editing events identified in each bulk DART-seq HEK293T cell replicate for Yth-E and E-Yth plasmids. Editing events identified in at least 2 replicates were considered for downstream analyses. The data was obtained following Apobec1-Yth-Egfp or Egfp-Apobec1-Yth transfection and EGFP FACS sorting. n=3, Rep: separately cultured replicate. (D) Metagene analysis showing m 6 A site counts along transcripts for Yth-E and E-Yth DART-seq results. 9% of all m 6 A sites occur in the first 10% of the 3’ UTR following the TTS for YTH-E, and 11% for E-YTH, respectively. Shown percentage indicates number of m 6 A sites upstream, within and downstream of coding sequence (CDS). (E) Metagene analysis showing m 6 A density 500nt 5’ and 500nt 3’ from stop codon (0nt) for YTH-E and E-YTH.

Article Snippet: HEK293T cells were purchased from Beijing Xiehe Cell Bank and cultured at 37°C with 5% CO2 in DMEM (Dulbecco’s Modified Eagle Medium) containing 10% FBS and 1% penicillin/streptomycin.

Techniques: Cell Culture, Mutagenesis, RNA Sequencing, Immunofluorescence, Transfection, Sequencing

V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.

Journal: Immunology

Article Title: The cytotoxic molecule granulysin is capable of inducing either chemotaxis or fugetaxis in dendritic cells depending on maturation: a role for V δ 2 + γδ T cells in the modulation of immune response to tumour?

doi: 10.1111/imm.13248

Figure Lengend Snippet: V δ 2 + γδ T cells release granulysin in response to tumour. (a) The expression of exhaustion markers PD‐1 and Lag‐3 on, and the secretion of granulysin by, V δ 2 + γδ T cells during the 9‐day expansion process. (b) The percentage of V δ 2 + γδ T cells to express early activation marker CD69 following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m zoledronic acid (ZA), as determined by flow cytometry. (c) The concentration of interferon‐ γ (IFN‐ γ ) found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (d) The percentage of V δ 2 + γδ T cells to express degranulation marker CD107a following 24, 48 or 72 hr of culture with Daudi cells, Raji cells or Raji cells pre‐treated for 24 hr with 5 μ m ZA, as determined by flow cytometry. (e) The concentration of granulysin found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (f) The concentration of granzyme B found within supernatants taken from 24, 48 or 72 hr co‐culture of V δ 2 + γδ T cells with tumour cell lines, as determined by ELISA. (g) Percentage killing of tumour cells by V δ 2 + γδ T cells following 24, 48 and 72 hr of culture, as determined by flow cytometry. Data shown are from six independent experiments, using V δ 2 + γδ T cells from six individual donors, with error bars (SD). Differences between groups were assessed by two‐way analysis of variance comparing negative control (V δ 2 + γδ T cells alone) with all other groups. * P < 0·05. ** P < 0·01. *** P < 0·001. **** P < 0·0001.

Article Snippet: Daudi and Raji B‐cell lymphoma lines (European Collection of Authenticated Cell Cultures, Salisbury, UK) were used in experiments as γδ T‐cell‐susceptible and ‐resistant target cells, respectively.

Techniques: Expressing, Activation Assay, Marker, Flow Cytometry, Concentration Assay, Co-Culture Assay, Enzyme-linked Immunosorbent Assay, Negative Control